Literature DB >> 27162472

Trifluridine/Tipiracil (Lonsurf) for the Treatment of Metastatic Colorectal Cancer.

Troy Kish, Priyasha Uppal.   

Abstract

Entities:  

Year:  2016        PMID： 27162472      PMCID： PMC4849340     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  8 in total

1.  Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3.

Authors:  Kylie A Hotchkiss; Anthony W Ashton; Edward L Schwartz
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

Review 2.  TAS-102 for the treatment of metastatic colorectal cancer.

Authors:  Lisa Salvatore; Daniele Rossini; Roberto Moretto; Chiara Cremolini; Marta Schirripa; Carlotta Antoniotti; Federica Marmorino; Fotios Loupakis; Alfredo Falcone; Gianluca Masi
Journal:  Expert Rev Anticancer Ther       Date:  2015-10-28       Impact factor: 4.512

3.  Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

Authors:  Robert J Mayer; Eric Van Cutsem; Alfredo Falcone; Takayuki Yoshino; Rocio Garcia-Carbonero; Nobuyuki Mizunuma; Kentaro Yamazaki; Yasuhiro Shimada; Josep Tabernero; Yoshito Komatsu; Alberto Sobrero; Eveline Boucher; Marc Peeters; Ben Tran; Heinz-Josef Lenz; Alberto Zaniboni; Howard Hochster; James M Cleary; Hans Prenen; Fabio Benedetti; Hirokazu Mizuguchi; Lukas Makris; Masanobu Ito; Atsushi Ohtsu
Journal:  N Engl J Med       Date:  2015-05-14       Impact factor: 91.245

4.  TAS-102: more than an antimetabolite.

Authors:  Godefridus J Peters; Irene V Bijnsdorp
Journal:  Lancet Oncol       Date:  2012-12       Impact factor: 41.316

5.  The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.

Authors:  S Matsushita; T Nitanda; T Furukawa; T Sumizawa; A Tani; K Nishimoto; S Akiba; K Miyadera; M Fukushima; Y Yamada; H Yoshida; T Kanzaki; S Akiyama
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

Review 6.  5-fluorouracil: mechanisms of action and clinical strategies.

Authors:  Daniel B Longley; D Paul Harkin; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

7.  Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells.

Authors:  Irene V Bijnsdorp; Godefridus J Peters; Olaf H Temmink; Masakazu Fukushima; Frank A Kruyt
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

8.  TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.

Authors:  Takayuki Yoshino; Nobuyuki Mizunuma; Kentaro Yamazaki; Tomohiro Nishina; Yoshito Komatsu; Hideo Baba; Akihito Tsuji; Kensei Yamaguchi; Kei Muro; Naotoshi Sugimoto; Yasushi Tsuji; Toshikazu Moriwaki; Taito Esaki; Chikuma Hamada; Takanori Tanase; Atsushi Ohtsu
Journal:  Lancet Oncol       Date:  2012-08-28       Impact factor: 41.316
  8 in total
  7 in total

1.  Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.

Authors:  Huan Liu; Zhiqiang Liu; Juan Du; Jin He; Pei Lin; Behrang Amini; Michael W Starbuck; Nora Novane; Jatin J Shah; Richard E Davis; Jian Hou; Robert F Gagel; Jing Yang
Journal:  Sci Transl Med       Date:  2016-08-24       Impact factor: 17.956

2.  Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo.

Authors:  Shan Lu; Obinna N Obianom; Yong Ai
Journal:  Medchemcomm       Date:  2018-08-27       Impact factor: 3.597

Review 3.  Structural biology of SARS-CoV-2: open the door for novel therapies.

Authors:  Weizhu Yan; Yanhui Zheng; Xiaotao Zeng; Bin He; Wei Cheng
Journal:  Signal Transduct Target Ther       Date:  2022-01-27

Review 4.  Use of Patient-Derived Organoids as a Treatment Selection Model for Colorectal Cancer: A Narrative Review.

Authors:  Sara Furbo; Paulo César Martins Urbano; Hans Henrik Raskov; Jesper Thorvald Troelsen; Anne-Marie Kanstrup Fiehn; Ismail Gögenur
Journal:  Cancers (Basel)       Date:  2022-02-20       Impact factor: 6.639

Review 5.  FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021.

Authors:  Aleksandra Sochacka-Ćwikła; Marcin Mączyński; Andrzej Regiec
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

Review 6.  Consensus on management of metastatic colorectal cancer in Central America and the Caribbean: San José, Costa Rica, August 2016.

Authors:  Roberto Ivan López; Jenny Lissette Castro; Heidy Cedeño; Dagoberto Cisneros; Luis Corrales; Ileana González-Herrera; Mayté Lima-Pérez; Rogelio Prestol; Roberto Salinas; Jorge Luis Soriano-García; Alejandra T Zavala; Luis Miguel Zetina; Carlos Eduardo Zúñiga-Orlich
Journal:  ESMO Open       Date:  2018-03-15

7.  Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme.

Authors:  Timothy Iveson; Angela M Carter; Kai-Keen Shiu; Clare Spooner; Daniel Stevens; Saifee Mullamitha
Journal:  BMC Cancer       Date:  2020-02-03       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.